GIUSSANI

New study led by Dino Giussani shows that changes in heart rate due to hypoxia in advaced pregnancies could be used to predict the future heart health of babies

Research by Dino Giussani's group have suggested that subtle changes to the drugs administered to mothers threatened with preterm birth or to premature babies could further improve clinical treatment and help increase their safety

Offspring whose mothers had a complicated pregnancy may be at greater risk of heart disease in later life, according to a new study in sheep by Dino Giussani's lab

Prof Giussani has received the prize from the International Society for Developmental Origins of Health & Disease

The environment in the womb as we first begin to grow may also determine our future: researchers from PDN, CTR and Barcroft center featured on the latest issue of Research Horizons.

Sildenafil may be a good candidate for human translational antioxidant therapy to protect fetal the developing cardiovascular system, reveals new study by Dino Giussani featured on the cover of the Journal of Physiology

The study published in the Journal of Physiology suggests that sildenafil is a good candidate for human therapy to protect the chronically hypoxic fetus in adverse pregnancy

The Royal College of Obstetrics & Gynaecology has awarded the title to Prof Giussani for his major contributions to obstetrics, gynaecology and to the wellbeing of women

The process of ageing begins even before we are born, according to an international team of researchers led by Dino Giussani. In a study using rats to model pregnancy and fetal development, the researchers also found that providing mothers with antioxidants during pregnancy meant that their offspring aged more slowly in adulthood.